Susquehanna International Group, LLP Pacific Biosciences Of California, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.2 - $2.17 $30,600 - $55,335	-25,500 Reduced 5.77%	416,100 $707,000
Q2 2024 Aug 15, 2024	BUY	$1.36 - $3.65 $10,608 - $28,470	7,800 Added 1.8%	441,600 $604,000
Q1 2024 May 07, 2024	BUY	$3.52 - $9.59 $867,680 - $2.36 Million	246,500 Added 131.61%	433,800 $1.63 Million
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $305,664 - $530,432	-51,200 Reduced 21.47%	187,300 $1.84 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $210,688 - $356,608	25,600 Added 12.02%	238,500 $1.99 Million
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $485,539 - $684,235	48,700 Added 29.66%	212,900 $2.83 Million
Q1 2023 May 16, 2023	BUY	$7.94 - $12.02 $89,722 - $135,826	11,300 Added 7.39%	164,200 $1.9 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $260,820 - $515,199	-46,000 Reduced 23.13%	152,900 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $246,411 - $537,339	62,700 Added 46.04%	198,900 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $117,785 - $305,599	29,300 Added 27.41%	136,200 $602,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $200,634 - $497,419	-23,800 Reduced 18.21%	106,900 $973,000
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $3.1 Million - $4.85 Million	-161,200 Reduced 55.22%	130,700 $2.67 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $2.93 Million - $4.12 Million	117,700 Added 67.57%	291,900 $7.46 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $686,840 - $1.11 Million	-30,800 Reduced 15.02%	174,200 $6.09 Million
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $2.71 Million - $5.26 Million	-102,800 Reduced 33.4%	205,000 $6.83 Million
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $2.95 Million - $8.02 Million	281,300 Added 1061.51%	307,800 $7.98 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $32,490 - $88,830	9,000 Added 51.43%	26,500 $262,000
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $43,725 - $66,495	-16,500 Reduced 48.53%	17,500 $60,000
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $113,516 - $253,006	-48,100 Reduced 58.59%	34,000 $104,000
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $53,819 - $65,169	-11,700 Reduced 12.47%	82,100 $422,000
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $381,236 - $470,624	76,400 Added 439.08%	93,800 $484,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $185,888 - $232,674	-31,400 Reduced 64.34%	17,400 $105,000
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $63,240 - $68,820	-9,300 Reduced 16.01%	48,800 $353,000
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $27,132 - $53,176	-6,800 Reduced 10.48%	58,100 $430,000
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $42,240 - $66,600	12,000 Added 22.68%	64,900 $351,000
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $20,678 - $38,416	9,800 Added 22.74%	52,900 $188,000
Q1 2018 May 15, 2018	SELL	$2.05 - $3.23 $74,415 - $117,249	-36,300 Reduced 45.72%	43,100 $88,000
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $29,267 - $61,472	-11,300 Reduced 12.46%	79,400 $210,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $290,240 - $505,199	90,700	90,700 $476,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.1 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$45.6 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$39.6 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.4 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account